Cocaine use and HIV disease progression among heterosexuals

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 4, 1996, Pages 229-236

  Larrat, E P ^a,b,e   Zierler, S ^a,c   Mayer, K ^a,c,d  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c Brown University AIDS Program   (United States)

^d MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^e 125 Fogarty Hall ^*  (United States)

Author keywords

Cocaine; Epidemiology; HIV

Indexed keywords

CD4 ANTIGEN; COCAINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG ABUSE; DRUG USE; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MALE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL;

EID: 0029786783     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199607)5:4<229::AID-PDS213>3.0.CO;2-6     Document Type: Article

References (32)

1. Friedman, S. and Lipton, D. In: Cocaine, Aids, and Intravenous Drug Use. Stimmel, B. (Ed.), Harrington Park Press, New York, 1990.
2. Friedman, S. and Lipton, D. In: Cocaine, Aids, and Drug Use. Stimmel, B. (Ed.), Harrington Park Press, New York, 1991.
3. Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A. and Moss, A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association 1989; 261(4): 561-565.
4. Des Jarlais, D. C. and Friedman, S. R. HIV infection among persons who inject illicit drugs: problems and prospects. Journal of Acquired Immune Deficiency Syndrome 1988; 1(3): 267-273.
5. Fullilove, R. E., Fullilove, M. T., Bowser, B. P. and Gross, S. A. Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif. Journal of the American Medical Association 1990; 263(6): 851-855.
6. Fullilove, M. T. and Fullilove, R. E. Intersecting epidemics: black teen crack use and sexually transmitted disease. Journal of the American Medicine Womans Association 1989; 44(5): 146-147.
7. Larrat, E., Zierler, S. and Mayer, K. Cocaine use and heterosexual exposure to HIV. Epidemiology 1994; 5(4): 398-403.
8. Fullilove, R. E., Fullilove, M. T., Bowser, B. and Gross, S. Crack users: the new AIDS risk group? Cancer Detection and Prevention 1990; 14(3): 363-368.
9. Steel, E. and Haverkos, H. Epidemiologic studies of HIV/AIDS and drug abuse. American Journal of Drug and Alcohol Abuse 1992; 18(2): 167-175.
10. Coates, R. A., Farewell, V. T., Raboud, J. et al. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. American Journal of Epidemiology 1990; 132(4): 717-722.
11. Hickson, M., Brown, L., Phillips, R. and Ajuluchukwu, D. Diseases commonly found in the drug abuser: is there more than HIV? NIDA 52nd Annual Scientific Meeting. National Institute of Drug Abuse, 1991; 486-487.
12. Minkoff, H. L., McCalla, S., Delke, I., Stevens, R., Sahven, M. and Feldman, J. The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women. American Journal of Obstetrics and Gynecology 1990; 163(2): 521-526.
13. Watzl, B. and Watson, R. Immunomodulation by cocaine - a neuroendocrine mediated response. Life Sciences 1990; 46: 1319-1329.
14. Lifson, A., Hessol, N. and Rutherford, G. Progression and clinical outcome of infection due to Human Immunodeficiency Virus. Clinics in Infectious Diseases 1991; 14: 966-972.
15. Lindsay, M. K., Feng, T. I., Peterson, H. B., Slade, B. A., Willis, S. and Klein, L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstetrics and Gynecology 1991; 77(4): 599-603.
16. Kaslow, R. A., Blackwelder, W. C, Ostrow, D. G., Lyter, D. and Coulson, A. H. Effects of illicit drugs and alcohol in expression of human immunodeficiency virus infection in gay/bisexual men. Clinical Research 1987; 35(3): 478A.
17. Biggar, R. J., Melbye, M., Ebbesen, P. et al. Low T-lymphocyte ratios in homosexual men. Journal of the American Medical Association 1984; 251: 1441-1446.
18. Crowe, S., Carlin, J. and Stewart, K. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. Journal of AIDS 1991; 4: 770-776.
19. Taylor, J., Fahey, J., Detels, R. and Giorgi, J. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. Journal of AIDS 1989; 2: 114-124.
20. Rothman, K. Modern Epidemiology. Little, Brown and Company, Boston, 1986.
21. Miettinen, O. Estimability and estimation in case-referent studies. American Journal of Epidemiology 1976; 103: 226-235.
22. Klein, T., Newton, C. and Friedman, H. Suppression of human and mouse lymphocyte proliferation by cocaine. In: Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. Bridge, P., Mirsky, A. and Goodwin, F. (Eds) Raven Press, New York, 1988, pp. 139-143.
23. Donahoe, R. Drug abuse and AIDS: causes for the connection. National Institute of Drug Abuse Research Monograph 1990; 96: 181-191.
24. Donahoe, R. and Falek, A. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS: In: Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. Bridge, P., Mirsky, A. and Goodwin, F. (Eds) Raven Press, New York, 1988, pp. 145-158.
25. Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Molitor, T. W. and Balfour, H. J. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. Journal of Immunology 1991; 146(1): 81-84.
26. Larrat, E. and Zierler, S. Entangled epidemics: cocaine use and HIV disease. American Journal of Psychoactive Drugs 1993; 25(3): 207-221.
27. Piette, J., Mor, V. and Fleishman, J. Patterns of survival with AIDS in the United States. HSR: Health Services Research 1991; 26(1): 75-95.
28. Stein, M., Piette, J., Mor, V. et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. Journal of General Internal Medicine 1991; 6: 35-40.
29. Brettle, R., Richardson, A., Burns, S., Fielding, K. and Leen, C. Survival analysis by gender and risk group for HIV in Edinburgh. VIII International Conference on AIDS, Amsterdam, the Netherlands, 1991.
30. Easterbrook, P., Margolick, J., Saah, A. et al. Racial differences in rate of CD4 decline in HIV-1 infected homosexual men. VIII International Conference on AIDS, Amsterdam, the Netherlands, 1992.
31. Van Griensven, G., Hessol, N., Koblin, B., Stevens, C., Katz, M. and Coutinho, R. Progression of HIV infection among homosexual men in HBV vaccine cohorts in Amsterdam, New York City and San Francisco. VIII International Conference on AIDS, Amsterdam, the Netherlands, 1992.
32. Bok, S. Informed consent in tests of patient reliability. Journal of the American Medical Association 1992; 267(8): 1118-1119.